Ligand Pharmaceuticals, Inc. (LGND) Tops Q1 EPS by 10c
Tweet
Share
E-mailGet Alerts LGND Hot Sheet
Price: $294.60 +2.00%
Financial Fact:
Net income (loss):: 1.05M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Net income (loss):: 1.05M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Ligand Pharmaceuticals, Inc. (NASDAQ: LGND) reported Q1 EPS of $0.35, $0.10 better than the analyst estimate of $0.25. Revenue for the quarter came in at $16 million versus the consensus estimate of $13.63 million.
For earnings history and earnings-related data on Ligand Pharmaceuticals, Inc. (LGND) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
- Leerink Starts Ligand Pharma (LGND) at Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
